R

Rational Vaccines

11 employees

Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Herpes Simplex Virus
Immunology
Health Care
Pharmaceutical
Vaccines
medical research
Virology

Date founded

2015

Funding rounds raised

Total raised

$10M

from 5 investors over 5 rounds

R

Rational Vaccines raised undisclosed on March 8, 2022

Investors: Globivest

R

Rational Vaccines raised $10M on December 4, 2020

Investors: Founders Fund, Arab Angel Fund, Presight Capital and Thiel Capital

FAQ